Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients

Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients

E&scedil;e Ba&scedil;bulut,1 Melek Bilgin,1 Hacer I&scedil;ler,1 Ahmet &Scedil;en,2 Süleyman S&inodot;rr&inodot; K&inodot;l&inodot;ç,3 Mahcube Çubukçu4 1Department of Medical Microbiology, Samsun Training and Research Hospital, Samsun, Turkey; 2Department of Anesthesi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Başbulut E, Bilgin M, İşler H, Şen A, Kılıç SS, Çubukçu M
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-11-01
Series:	Risk Management and Healthcare Policy
Subjects:	covid-19 measles rubella antibody sars-cov-2 immunogloulin g
Online Access:	https://www.dovepress.com/analysis-of-measles-and-rubella-immunoglobulin-g-titers-in-covid-19-pa-peer-reviewed-fulltext-article-RMHP
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.
by: G. M. Daragan, et al.
Published: (2018-04-01)

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean
by: Tracy Evans-Gilbert, et al.
Published: (2024-12-01)

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas
by: Jon K. Andrus, et al.
Published: (2024-12-01)

Progress of Measles and Rubella Surveillance in the Context of Measles Elimination in the WHO Eastern Mediterranean Region, 2019–2022
by: Muhammad Farid, et al.
Published: (2024-11-01)

Global challenges and solutions to achieving and sustaining measles and rubella elimination
by: Natasha S. Crowcroft, et al.
Published: (2024-12-01)

Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
by: Darin Zehrung, et al.
Published: (2024-11-01)

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination
by: Kimberly M. Thompson
Published: (2024-10-01)

Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018
by: Adjoane Mauricio Silva Maciel, et al.
Published: (2024-12-01)

Incidence of measles specific IgG antibody among children in Adamawa State, Nigeria
by: Isa, H., et al.
Published: (2019-06-01)

Rubella antibody levels in the healthy Chinese population: a meta-analysis
by: Yaning Zhuo, et al.
Published: (2024-11-01)

Measles-mumps-rubella vaccination experience in children with egg allergy
by: Öner Özdemir, et al.
Published: (2024-02-01)

Peran Measles-Containing-Vaccine dalam Pencegahan Coronavirus Disease 2019 (COVID-19)
by: Diandra Tatiana, et al.
Published: (2024-12-01)

Seroprevalence Survey of Rubella IgG Antibodies among Pregnant Women Attending Antenatal Clinics in Abakaliki, Ebonyi State, Nigeria
by: Ekuma, Uchechukwu Onyeukwu, et al.
Published: (2018-12-01)

Epidemiological characteristics of rubella in Wuxi City from 2015 to 2023
by: YANG Xu, WANG Xuwen
Published: (2025-01-01)

Methicillin-resistant Staphylococcus Aureus Bacteraemia in a Young Boy following Mumps Infection: A Case Report
by: Jayakanthan Saravanan, et al.
Published: (2025-01-01)

Seroprevalence of measles antibody among immigrants in Gwangju, South Korea
by: Ran Lee, et al.
Published: (2024-12-01)

Low IgG Seroconversion among Persons Vaccinated against Measles, Republic of Congo
by: Yanne Vanessa Thiécesse Mavoungou, et al.
Published: (2025-01-01)

Assessment of Simplified Surveillance for Congenital Rubella Syndrome in Sudan, 2014–2017
by: Omayma Abdalla, et al.
Published: (2024-12-01)

Measles Outbreaks in Afghanistan
by: Abubakr Yosufi, et al.
Published: (2024-03-01)

Contagion comeback: unravelling the measles outbreak across the USA
by: Iman Muhammad Tahir, et al.
Published: (2024-12-01)

Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female Sex
by: Benjamin Vlad, et al.
Published: (2024-12-01)

Molecular epidemiology of rubella during the pre- and post-elimination eras in the Americas
by: Min-hsin Chen, et al.
Published: (2024-12-01)

An Outbreak of Measles in Iraq
by: Raid Al-Ani, et al.
Published: (2024-06-01)

Rubella associated with hemophagocytic syndrome. First report in a male and review of the literature
by: Makram Koubaa, et al.
Published: (2012-01-01)

Rubella associated with hemophagocytic syndrome. First report in a male and review of the literature
by: Makram Koubaa, et al.
Published: (2012-08-01)

Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles eliminationResearch in context
by: Somya Mehra, et al.
Published: (2025-01-01)

Neutralizing antibody titers after COVID-19 vaccination
by: Safoora Shirani Shams Abadi, et al.
Published: (2024-11-01)

Seroepidemiological study of the prevalence of SARS-CoV-2 antibodies (IgG and IgM) positive titers in the population, referring to the laboratories of Urmia city
by: Mohammad Hassan Ansari, et al.
Published: (2024-11-01)

Measles seroprevalence in Thailand: are adolescents and young adults at risk of measles?
by: Panit Takkinsatian, et al.
Published: (2024-06-01)

Resurgence of Mumps among Lower Socioeconomic Class of Children in Ahmedabad: A Cross-sectional Study of 115 Cases in a Tertiary Care Center
by: Dipti V Patel, et al.
Published: (2024-05-01)

Trend and forecast of measles disease, in East Gojjam Zone, Amhara Region, Northwest Ethiopia, 2023: a crossectional study
by: Habitamu Wudu, et al.
Published: (2024-12-01)

Insights from epidemiological game theory into gender-specific vaccination against rubella
by: Eunha Shim, et al.
Published: (2009-08-01)

A simple analysis of vaccination strategies for rubella
by: Bruno Buonomo
Published: (2011-05-01)

Measles (lecture, continuing)
by: Shostakovych-Koretsraya L.R., et al.
Published: (2013-12-01)

A Cross-sectional Study to Understand the Reasons for Failure to Vaccinate Eligible Children with Measles-containing Vaccine among the Clinically Diagnosed Measles Cases during the Outbreak (2022) in a District of Maharashtra
by: Sudhir V Sane, et al.
Published: (2024-03-01)

Securing long-term immunity: The possible necessity of supplementary measles vaccination
by: Furkan Kalayci, et al.
Published: (2024-11-01)

Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia
by: Kalkidan Solomon, et al.
Published: (2024-06-01)

Optimization and control in rubella transmission dynamics: A boundedness-preserving numerical model with vaccination
by: Samiullah Salim, et al.
Published: (2024-01-01)

Vaccination coverage, delay and loss to follow-up of the triple viral vaccine, in live births between 2017 and 2018 in Brazilian cities
by: Tatiana Lang D’Agostini, et al.
Published: (2024-12-01)

Factors influencing the unexpected measles outbreak of 2023 in Colombo, Sri Lanka
by: Kasunee Kalubowila, et al.
Published: (2025-01-01)